Resource Center on Keeping Up With Your HIV Care

Our updated medical advice from HIV doctors and health experts on how to remain healthy during the COVID-19 pandemic if you're living with HIV in the U.S., including guidance on vaccines.

Two weeks after you receive the last required dose of vaccine, you can visit with other fully vaccinated people indoors without wearing masks or staying 6 feet apart.

As of our most recent update, 12 states have added all PLWH to their Phase 1c rollout, but prioritization is changing rapidly as states develop their plans and additional vaccine doses become available.

From dosing to side effects to drug interactions and everything in between, here's all the basics on the first-ever injectable treatment regimen for HIV.

Appreciating the breakthrough is one thing. Actually making the switch is another.

An old HIV medication that's still a part of many people's treatment regimens, there's plenty to know about what makes this “booster” drug tick—and why it has such a long-lived history.

Will PLWH in the U.S. be prioritized to receive a COVID-19 vaccine? Is the vaccine safe for PLWH? Here's the latest.

Whether it’s remdesivir, corticosteroids, convalescent plasma, or monoclonal antibodies, we’ve got the latest expert info on what people living with HIV and their clinicians need to keep in mind.

It's the oldest single-tablet regimen for HIV. But is it washed up as a viable treatment option? Here's a top expert's take.

It’s not considered a “preferred” option for starting HIV treatment in the U.S., but Genvoya still has its place in our medication arsenal.